| Selective receptor modulator | |
|---|---|
| Drug class | |
 Tamoxifen, a SERMTooltip selective estrogen receptor modulator and a widely used drug in the treatment of breast cancer. | |
| Class identifiers | |
| Synonyms | SRM |
| Use | Various |
| Biological target | Steroid hormone receptor |
| Chemical class | Steroidal; Nonsteroidal |
| Legal status | |
| In Wikidata | |
In the field of pharmacology, a selective receptor modulator or SRM is a type of drug that has different effects in different tissues. A SRM may behave as an agonist in some tissues while as an antagonist in others. Hence selective receptor modulators are sometimes referred to as tissue selective drugs or mixed agonists / antagonists. This tissue selective behavior is in contrast to many other drugs that behave either as agonists or antagonists regardless of the tissue in question.
Classes
Classes of selective receptor modulators include:
- Selective androgen receptor modulator (SARM)
- Selective estrogen receptor modulator (SERM)
- Selective glucocorticoid receptor modulator (SEGRM)
- Selective progesterone receptor modulator (SPRM)
- Selective PPAR modulator (SPPARM) including SPPARMγ (affecting the PPARγ) and SPPARMα (PPARα)
See also
References
- Smith CL, O'Malley BW (February 2004). "Coregulator function: a key to understanding tissue specificity of selective receptor modulators". Endocr. Rev. 25 (1): 45–71. doi:10.1210/er.2003-0023. PMID 14769827.
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |